A detailed history of Fil LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Fil LTD holds 83,516 shares of ABT stock, worth $9.68 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
83,516
Previous 351,291 76.23%
Holding current value
$9.68 Million
Previous $36.5 Million 73.92%
% of portfolio
0.01%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $26.8 Million - $31.6 Million
-267,775 Reduced 76.23%
83,516 $9.52 Million
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $3.03 Million - $3.38 Million
-30,100 Reduced 7.89%
351,291 $36.5 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $21.4 Million - $23.7 Million
195,613 Added 105.29%
381,391 $43.3 Million
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $14.3 Million - $17.6 Million
159,078 Added 595.8%
185,778 $20.4 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $234,144 - $280,933
2,451 Added 10.11%
26,700 $2.59 Million
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $1.95 Million - $2.17 Million
-19,324 Reduced 44.35%
24,249 $2.64 Million
Q1 2023

May 11, 2023

SELL
$96.86 - $114.01 $3.7 Million - $4.35 Million
-38,181 Reduced 46.7%
43,573 $4.41 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $497,448 - $583,584
5,233 Added 6.84%
81,754 $8.98 Million
Q3 2022

Nov 10, 2022

SELL
$96.76 - $112.03 $14.9 Million - $17.2 Million
-153,700 Reduced 66.76%
76,521 $7.4 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $382,558 - $462,390
3,748 Added 1.65%
230,221 $25 Million
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $3.52 Million - $4.29 Million
-30,867 Reduced 11.99%
226,473 $26.8 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $3.3 Million - $4.04 Million
28,558 Added 12.48%
257,340 $36.2 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $9.68 Million - $10.7 Million
-82,950 Reduced 26.61%
228,782 $27 Million
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $26.9 Million - $31.7 Million
-254,400 Reduced 44.94%
311,732 $36.1 Million
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $23.6 Million - $27.8 Million
216,983 Added 62.15%
566,132 $67.8 Million
Q4 2020

Feb 08, 2021

SELL
$105.0 - $114.42 $60.3 Million - $65.8 Million
-574,761 Reduced 62.21%
349,149 $38.2 Million
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $1.24 Million - $1.5 Million
-13,519 Reduced 1.44%
923,910 $101 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $14.3 Million - $18.2 Million
-186,218 Reduced 16.57%
937,429 $85.7 Million
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $49.2 Million - $72 Million
-783,333 Reduced 41.08%
1,123,647 $88.7 Million
Q4 2019

Feb 07, 2020

SELL
$78.51 - $87.4 $124 Million - $138 Million
-1,578,630 Reduced 45.29%
1,906,980 $166 Million
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $128 Million - $139 Million
-1,568,592 Reduced 31.04%
3,485,610 $292 Million
Q2 2019

Aug 13, 2019

SELL
$72.88 - $85.0 $27.9 Million - $32.6 Million
-383,488 Reduced 7.05%
5,054,202 $425 Million
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $49.6 Million - $59.9 Million
-748,551 Reduced 12.1%
5,437,690 $435 Million
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $138 Million - $157 Million
-2,107,377 Reduced 25.41%
6,186,241 $447 Million
Q3 2018

Nov 09, 2018

BUY
$60.81 - $73.36 $28.8 Million - $34.8 Million
473,765 Added 6.06%
8,293,618 $608 Million
Q2 2018

Aug 10, 2018

SELL
$57.57 - $63.54 $97.3 Million - $107 Million
-1,689,762 Reduced 17.77%
7,819,853 $477 Million
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $21.8 Million - $24.7 Million
-388,086 Reduced 3.92%
9,509,615 $570 Million
Q4 2017

Feb 12, 2018

SELL
$53.68 - $57.47 $96.2 Million - $103 Million
-1,791,682 Reduced 15.33%
9,897,701 $565 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $72.1 Million - $80.5 Million
1,500,140 Added 14.72%
11,689,383 $624 Million
Q2 2017

Aug 29, 2017

BUY
N/A
10,189,243
10,189,243 $495 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.